Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01784068
Title Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Facility Status City State Zip Country Details
Florida Cancer Specialists FL Cancer Specialists Fort Myers Florida 33901 United States Details
Lakes Research SC Miami Lakes Florida 33014 United States Details
H Lee Moffitt Cancer Center and Research Institute SC - 5 Tampa Florida 33612 United States Details
Cancer Center of Kansas SC Wichita Kansas 67214-3728 United States Details
Dana Farber Cancer Institute SC - 8 Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering SC New York New York 10017 United States Details
Oregon Health and Science University SC-6 Portland Oregon 97239 United States Details
Cancer Centers of the Carolinas Cancer Centers of Carolinas (3 Greenville South Carolina 29605 United States Details
Sarah Cannon Research Institute Sarah Cannon Research Nashville Tennessee 37203 United States Details
Community Cancer Trials of Utah Ogden Utah 84405 United States Details
Novartis Investigative Site Buenos Aires C1114AAN Argentina Details
Novartis Investigative Site Graz A-8036 Austria Details
Novartis Investigative Site Rankweil A-6830 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Wien 1140 Austria Details
Novartis Investigative Site Jette Brussel 1090 Belgium Details
Novartis Investigative Site Sint Niklaas Vlaams Brabant 9100 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Charleroi 6000 Belgium Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Kortrijk 8500 Belgium Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Varna 9000 Bulgaria Details
Novartis Investigative Site Bogota Cundinamarca 111411 Colombia Details
Novartis Investigative Site Monteria Colombia Details
Novartis Investigative Site Aarhus 8000 Denmark Details
Novartis Investigative Site Bayonne Bayonne Cedex 64109 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Brest 29200 France Details
Novartis Investigative Site Corbeil Essonnes 91100 France Details
Novartis Investigative Site Dunkerque 59240 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Nantes Cedex 1 44093 France Details
Novartis Investigative Site Rouen Cedex 1 76038 France Details
Novartis Investigative Site Saint Priest en Jarez 42271 France Details
Novartis Investigative Site Strasbourg cedex 67085 France Details
Novartis Investigative Site Strasbourg 67098 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Luebeck Schleswig-holstein 23563 Germany Details
Novartis Investigative Site Aachen 52074 Germany Details
Novartis Investigative Site Bayreuth 95445 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Bottrop 46236 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Duesseldorf 40225 Germany Details
Novartis Investigative Site Duesseldorf 40479 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Freiburg 79106 Germany Details
Novartis Investigative Site Goslar 38642 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hamburg 22417 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Magdeburg 39104 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Stuttgart 70376 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Athens GR 115 27 Greece Details
Novartis Investigative Site Athens 106 76 Greece Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Budapest 1085 Hungary Details
Novartis Investigative Site Budapest H-1097 Hungary Details
Novartis Investigative Site Szeged H 6725 Hungary Details
Novartis Investigative Site Dublin DUBLIN 8 Ireland Details
Novartis Investigative Site Galway Ireland Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Cona FE 44100 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Nuoro NU 08100 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Terni TR 05100 Italy Details
Novartis Investigative Site Napoli 80132 Italy Details
Novartis Investigative Site Novara 28100 Italy Details
Novartis Investigative Site Kashiwa-city Chiba 277-8567 Japan Details
Novartis Investigative Site Sapporo city Hokkaido 060 8648 Japan Details
Novartis Investigative Site Sagamihara-city Kanagawa 252-0375 Japan Details
Novartis Investigative Site Kumamoto City Kumamoto 860-8556 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Suita city Osaka 565 0871 Japan Details
Novartis Investigative Site Saga-city Saga 849-8501 Japan Details
Novartis Investigative Site Kawagoe Saitama 350 8550 Japan Details
Novartis Investigative Site Shimotsuga Gun Tochigi 321-0293 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8519 Japan Details
Novartis Investigative Site Shinjuku-ku Tokyo 160-0023 Japan Details
Novartis Investigative Site Akita 010-8543 Japan Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Gdansk 80-952 Poland Details
Novartis Investigative Site Warszawa 02 106 Poland Details
Novartis Investigative Site Oviedo Asturias 33006 Spain Details
Novartis Investigative Site Tarragona Catalunya 43005 Spain Details
Novartis Investigative Site Terrassa Catalunya 08221 Spain Details
Novartis Investigative Site Orense Galicia 32005 Spain Details
Novartis Investigative Site Las Palmas de Gran Canaria Las Palmas De G.C 35010 Spain Details
Novartis Investigative Site Pamplona Navarra 31008 Spain Details
Novartis Investigative Site La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Baracaldo Vizcaya 48903 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28006 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Lund SE-221 85 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Uppsala SE-751 85 Sweden Details
Novartis Investigative Site Cardiff CF14 4XW United Kingdom Details
Novartis Investigative Site Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field